Extended Treatment for Smoking Cessation
Extended Treatment for Smoking Cessation
批准号:
8505434
负责人:
SEAN P. DAVID
金额:
$51.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2016-06-30
关键词:
21 year oldAbstinenceAddressAdolescentAdultAirBehavioralBupropionCarbon MonoxideCellsCellular PhoneChronicClinical TrialsCocaine DependenceCognitiveCognitive TherapyComputersControlled StudyCounselingCountyCox Proportional Hazards ModelsDetectionDevelopmentDiseaseDrug AddictionEarly DiagnosisEligibility DeterminationEvent History AnalysisIntentionKnowledgeLogistic RegressionsMaintenanceMeasuresMediator of activation proteinModelingMonitorNicotineOpiate AddictionOutcomeOutcome MeasureParticipantPharmacotherapyPhasePopulation StudyPrevalenceProbabilityPublic HealthRandomizedRecommendationRelapseReportingResearchSamplingSelection BiasSmokeSmokerSmokingSocietiesSupportive careSurvival AnalysisTailTarget PopulationsTechniquesTechnologyTelephoneTimeTobaccoTreatment FailureWithholding TreatmentWorkWritingalcoholism therapybasecigarette smokingcravingdepressive symptomsdesigndisorder later incidence preventionexperiencefollow-upmeetingsnicotine patchopen labelprimary outcomepublic health relevancerapid detectionresponsesecondary outcomeself helpskills trainingsmoking cessationsuccesstreatment planningtreatment responsevarenicline
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Research indicates that drug addictions are chronic, relapsing disorders requiring extended therapy and follow-up. However, only a few smoking cessation trials have examined the utility of extended therapy models. We propose to examine the efficacy of a multi-component extended cigarette smoking cessation treatment in promoting longer-term smoking abstinence. Adult smokers and adolescent smokers (18 - 21) years of age will serve as the target population for this study. A total of 400 smokers will be randomized. Treatment will include both open label and extended treatment phases. Open Label Treatment. All 400 smokers will receive nicotine patch (21mg), bupropion (300mg) and individualized cognitive and behavioral skills training (ST). Nicotine patches and bupropion will be provided for 10 weeks and cognitive behavior therapy (CBT) will be provided for 26 weeks. Those who fail to respond to bupropion and nicotine patch will be switched to varenicline through week 26. Those who relapse beyond week 10 will re-start bupropion and nicotine patch through week 26. Extended Treatment. Following open label treatment, half (n=200) will receive CBT from week 26 - week 52. CBT will include both therapist-directed and self-directed relapse prevention skills training. In addition, telephone counseling will be provided in conjunction with voicemail, computer and cell phone technology enabling monitoring of treatment plan implementation and early detection of smoking "slips" and rapid response by treatment staff. Control. Remaining participants (n=200) will receive monthly telephone support calls from week 26 - week 52. The proposed study will address several important gaps in our knowledge of effective smoking cessation treatment. First, this will be one of only a handful of studies to investigate the effects of extended therapy for smoking cessation. Second, this will be among the first controlled studies to examine the effects of a multi-component treatment employing pharmacotherapy, intensive behavioral skills training, self-help skills training and rapid slip detection and response via voicemail, cell phone and telephone counseling.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention.
DOI:
10.1016/j.tics.2014.02.010
发表时间:
2014-05
期刊:
TRENDS IN COGNITIVE SCIENCES
影响因子:
19.9
作者:
[Ioannidis, John P. A., Munafo, Marcus R., Fusar-Poli, Paolo, Nosek, Brian A., David, Sean P.]
通讯作者:
David, Sean P.
DOI:
10.1111/add.13806
发表时间:
2017
期刊:
Addiction (Abingdon, England)
影响因子:
--
作者:
[Laude,JenniferR, Bailey,SteffaniR, Crew,Erin, Varady,Ann, Lembke,Anna, McFall,Danielle, Jeon,Anna, Killen,Diana, Killen,JoelD, David,SeanP]
通讯作者:
David,SeanP
DOI:
10.1371/journal.pone.0070104
发表时间:
2013
期刊:
PloS one
影响因子:
3.7
作者:
[David SP, Ware JJ, Chu IM, Loftus PD, Fusar-Poli P, Radua J, Munafò MR, Ioannidis JP]
通讯作者:
Ioannidis JP
Exploratory/Developmental Study of Pharmacogenetic Smoking Cessation Therapy
-
批准号:7782802
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2009
-
负责人:SEAN P. DAVID
-
依托单位:
Exploratory/Developmental Study of Pharmacogenetic Smoking Cessation Therapy
-
批准号:7845112
-
项目类别:
-
资助金额:$16.36万
-
财政年份:2009
-
负责人:SEAN P. DAVID
-
依托单位:
Extended Treatment for Smoking Cessation
-
批准号:7928755
-
项目类别:
-
资助金额:$60.3万
-
财政年份:2003
-
负责人:SEAN P. DAVID
-
依托单位:
Extended Treatment for Smoking Cessation
-
批准号:8281698
-
项目类别:
-
资助金额:$56.8万
-
财政年份:2003
-
负责人:SEAN P. DAVID
-
依托单位:
Primary Care Genetics Cancer Prevention Conference
-
批准号:6652383
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2003
-
负责人:SEAN P. DAVID
-
依托单位:
Extended Treatment for Smoking Cessation
-
批准号:8091208
-
项目类别:
-
资助金额:$58.55万
-
财政年份:2003
-
负责人:SEAN P. DAVID
-
依托单位:
Psychobiological /Genetic Determinants-Smoking Cessation
-
批准号:6937777
-
项目类别:
-
资助金额:$15.73万
-
财政年份:2002
-
负责人:SEAN P. DAVID
-
依托单位:
Psychobiological /Genetic Determinants-Smoking Cessation
-
批准号:6582643
-
项目类别:
-
资助金额:$15.67万
-
财政年份:2002
-
负责人:SEAN P. DAVID
-
依托单位:
Psychobiological /Genetic Determinants-Smoking Cessation
-
批准号:6800391
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2002
-
负责人:SEAN P. DAVID
-
依托单位:
Psychobiological /Genetic Determinants-Smoking Cessation
-
批准号:7106368
-
项目类别:
-
资助金额:$16.11万
-
财政年份:2002
-
负责人:SEAN P. DAVID
-
依托单位:
Psychobiological /Genetic Determinants-Smoking Cessation
-
批准号:6667118
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2002
-
负责人:SEAN P. DAVID
-
依托单位:
海外基金